Circulation. 2005;111:e394-e434
doi: 10.1161/CIRCULATIONAHA.105.165564
doi: 10.1161/CIRCULATIONAHA.105.165564
(Circulation. 2005;111:e394-e434.)
© 2005 American Heart Association, Inc.
AHA Scientific Statement |
Infective Endocarditis
Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Correspondence to Kathryn A. Taubert, PhD, FAHA, American Heart Association, 7272 Greenville Ave, Dallas, TX 75231. E-mail Ktaubert{at}heart.org
Background— Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness.
Methods and Results— This work represents the third iteration of an infective endocarditis "treatment" document developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It updates recommendations for diagnosis, treatment, and management of complications of infective endocarditis. A multidisciplinary committee of experts drafted this document to assist physicians in the evolving care of patients with infective endocarditis in the new millennium. This extensive document is accompanied by an executive summary that covers the key points of the diagnosis, antimicrobial therapy, and management of infective endocarditis. For the first time, an evidence-based scoring system that is used by the American College of Cardiology and the American Heart Association was applied to treatment recommendations. Tables also have been included that provide input on the use of echocardiography during diagnosis and treatment of infective endocarditis, evaluation and treatment of culture-negative endocarditis, and short-term and long-term management of patients during and after completion of antimicrobial treatment. To assist physicians who care for children, pediatric dosing was added to each treatment regimen.
Conclusions— The recommendations outlined in this update should assist physicians in all aspects of patient care in the diagnosis, medical and surgical treatment, and follow-up of infective endocarditis, as well as management of associated complications. Clinical variability and complexity in infective endocarditis, however, dictate that these guidelines be used to support and not supplant physician-directed decisions in individual patient management.
Key Words: AHA Scientific Statements • endocardium • drugs • echocardiography • infection
This article has been cited by other articles:
 |
|
 |
|
  C. Bech, B. Huttner, J. A. Patterson, and J.-J. Perrenoud Unusual evolution of a non-hacek Gram-negative endocarditis in a patient with Turner syndrome Age Ageing, July 1, 2009; 38(4): 485 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Masliah-Planchon, G. Breton, V. Jarlier, A. Simon, O. Benveniste, S. Herson, and L. Drieux Endocarditis Due to Neisseria bacilliformis in a Patient with a Bicuspid Aortic Valve J. Clin. Microbiol., June 1, 2009; 47(6): 1973 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Hughes, C. R. Frei, P. R. Maxwell, K. Green, J. E. Patterson, G. E. Crawford, and J. S. Lewis II Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2014 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rehm, M. Campion, D. E. Katz, R. Russo, and H. W. Boucher Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy J. Antimicrob. Chemother., May 1, 2009; 63(5): 1034 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V H Chu, J M Miro, B Hoen, C H Cabell, P A Pappas, P Jones, M E Stryjewski, I Anguera, S Braun, P Munoz, et al. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study Heart, April 1, 2009; 95(7): 570 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Sy, C. Chawantanpipat, D. R. Richmond, and L. Kritharides Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis Eur. Heart J., March 28, 2009; (2009) ehp085v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Thuny, S. Beurtheret, J. Mancini, V. Gariboldi, J.-P. Casalta, A. Riberi, R. Giorgi, F. Gouriet, L. Tafanelli, J.-F. Avierinos, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis Eur. Heart J., March 26, 2009; (2009) ehp089v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bannay, B. Hoen, X. Duval, J.-F. Obadia, C. Selton-Suty, V. Le Moing, P. Tattevin, B. Iung, F. Delahaye, F. Alla, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur. Heart J., February 9, 2009; (2009) ehp008v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Leibovici, L. Vidal, and M. Paul Aminoglycoside drugs in clinical practice: an evidence-based approach J. Antimicrob. Chemother., February 1, 2009; 63(2): 246 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Leonard and M. J. Rybak Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations J. Antimicrob. Chemother., January 1, 2009; 63(1): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Rehm, H. Boucher, D. Levine, M. Campion, B. I. Eisenstein, G. A. Vigliani, G.R. Corey, and E. Abrutyn Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates J. Antimicrob. Chemother., December 1, 2008; 62(6): 1413 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Rose, S. N. Leonard, and M. J. Rybak Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3061 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Munoz, E. Bouza, M. Marin, L. Alcala, M. Rodriguez Creixems, M. Valerio, A. Pinto, and on behalf of the Group for the Management of Infec Heart Valves Should Not Be Routinely Cultured J. Clin. Microbiol., September 1, 2008; 46(9): 2897 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Nishimura, B. A. Carabello, D. P. Faxon, M. D. Freed, B. W. Lytle, P. T. O'Gara, R. A. O'Rourke, and P. M. Shah ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 19, 2008; 52(8): 676 - 685. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Nishimura, B. A. Carabello, D. P. Faxon, M. D. Freed, B. W. Lytle, P. T. O'Gara, R. A. O'Rourke, and P. M. Shah ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, August 19, 2008; 118(8): 887 - 896. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Pai, M. L. Samples, R.-C. Mercier, and M. N. Spilde Activities and Ultrastructural Effects of Antifungal Combinations against Simulated Candida Endocardial Vegetations Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2367 - 2376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Robertson, E. J. Bonventre, T. B. Doyle, Q. Du, L. Duncan, T. W. Morris, E. D. Roche, D. Yan, and A. S. Lynch In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2313 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Riedel, E. Weekes, and G. N. Forrest Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus aureus Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2463 - 2467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chandrikakumari, J. B. Giot, L. de Leval, E. Creemers, P. Leonard, D. Mukeba, M. Moutschen, and F. Frippiat Report of a Case of Streptococcus agalactiae Mycotic Aneurysm and Review of the Literature International Journal of Surgical Pathology, July 1, 2008; 16(3): 314 - 319. [Abstract] [PDF]
|
|
|
|
 |
|
 J. D. Hartzell, R. N. Wood-Morris, L. J. Martinez, and R. F. Trotta Q Fever: Epidemiology, Diagnosis, and Treatment Mayo Clin. Proc., May 1, 2008; 83(5): 574 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Troise, G. F. Guarnieri, N. Laforgia, M. R. Tagliente, T. Pirolo, P. Arciprete, and L. de Luca Tupputi Schinosa Multidisciplinary approach in a case of successful surgical treatment of a voluminous intracardiac fungal mass in an infant Eur J Echocardiogr, May 1, 2008; 9(3): 317 - 318. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. REHM Staphylococcus aureus: The new adventures of a legendary pathogen Cleveland Clinic Journal of Medicine, March 1, 2008; 75(3): 177 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rouzet, M. D. Hernandez, F. Hervatin, L. Sarda-Mantel, A. Lefort, X. Duval, L. Louedec, B. Fantin, D. Le Guludec, and J.-B. Michel Technetium 99m-Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis Circulation, February 12, 2008; 117(6): 781 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. M. Verhagen, J. Hermanides, J. C. Korevaar, P. M. M. Bossuyt, R. B. A. van den Brink, P. Speelman, and J. T. M. van der Meer Prognostic Value of Serial C-Reactive Protein Measurements in Left-Sided Native Valve Endocarditis Arch Intern Med, February 11, 2008; 168(3): 302 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Millar, B. D. Prendergast, and J. E. Moore Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis J. Antimicrob. Chemother., January 1, 2008; 61(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group J Am Dent Assoc, January 1, 2008; 139(suppl_1): 3S - 24S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Sohail, D. Z. Uslan, A. H. Khan, P. A. Friedman, D. L. Hayes, W. R. Wilson, J. M. Steckelberg, S. M. Jenkins, and L. M. Baddour Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection Mayo Clin. Proc., January 1, 2008; 83(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Avierinos, F. Thuny, V. Chalvignac, R. Giorgi, L. Tafanelli, J.-P. Casalta, D. Raoult, T. Mesana, F. Collart, D. Metras, et al. Surgical Treatment of Active Aortic Endocarditis: Homografts Are Not the Cornerstone of Outcome Ann. Thorac. Surg., December 1, 2007; 84(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Vikram, A. K. Bacani, P. A. DeValeria, S. A. Cunningham, and F. R. Cockerill III Bivalvular Bartonella henselae Prosthetic Valve Endocarditis J. Clin. Microbiol., December 1, 2007; 45(12): 4081 - 4084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al. Prevention of Infective Endocarditis: Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, October 9, 2007; 116(15): 1736 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nucifora, L. P. Badano, P. Viale, P. Gianfagna, G. Allocca, D. Montanaro, U. Livi, and P. M. Fioretti Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge Eur. Heart J., October 1, 2007; 28(19): 2307 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A Mergenhagen and M. T Pasko Daptomycin Use After Vancomycin-Induced Neutropenia in a Patient with Left-Sided Endocarditis Ann. Pharmacother., September 1, 2007; 41(9): 1531 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Skiadas, A. Pefanis, A. Papalois, A. Kyroudi, H. Triantafyllidi, T. Tsaganos, and H. Giamarellou Dexamethasone as Adjuvant Therapy to Moxifloxacin Attenuates Valve Destruction in Experimental Aortic Valve Endocarditis Due to Staphylococcus aureus Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2848 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Falagas, K. P. Giannopoulou, F. Ntziora, and K. Z. Vardakas Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence J. Antimicrob. Chemother., July 1, 2007; 60(1): 7 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Musci, H. Siniawski, M. Pasic, O. Grauhan, Y. Weng, R. Meyer, C. A. Yankah, and R. Hetzer Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 118 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Miro, C. Garcia-de-la-Maria, Y. Armero, E. de-Lazzari, D. Soy, A. Moreno, A. del Rio, M. Almela, C. A. Mestres, J. M. Gatell, et al. Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2373 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Greig, C. E. O'Sullivan, O. Adam, H. H. Klein, and H.-J. Schafers Intraaortic Vegetations and Infective Endocarditis N. Engl. J. Med., June 7, 2007; 356(23): 2430 - 2431. [Full Text] [PDF]
|
|
|
|
|
|
W. Wilson, K. A. Taubert, M. Gewitz, P. B. Lockhart, L. M. Baddour, M. Levison, A. Bolger, C. H. Cabell, M. Takahashi, R. S. Baltimore, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group J Am Dent Assoc, June 1, 2007; 138(6): 739 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kamalakannan, R. M. Pai, L. B. Johnson, J. M. Gardin, and L. D. Saravolatz Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients Ann. Thorac. Surg., June 1, 2007; 83(6): 2081 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Chee and D. N. Mohr 71-Year-Old Woman With Fever and Altered Mental Status Mayo Clin. Proc., February 1, 2007; 82(2): 237 - 240. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Skubas, R. L. Slepian, L. Y. Lee, and A. J. Tortolani Tricuspid Regurgitation Caused by Eustachian Valve Endocarditis Anesth. Analg., December 1, 2006; 103(6): 1410 - 1411. [Full Text] [PDF]
|
|
|
|
|
|
B. Hoen Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart, November 1, 2006; 92(11): 1694 - 1700. [Full Text] [PDF]
|
|
|
|
|
|
H. J. Fadel, G. Kumar, and T. J. Beckman 58-Year-Old Man With Fever and Right Eye Pain Mayo Clin. Proc., September 1, 2006; 81(9): 1238 - 1240. [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Beynon, V K Bahl, and B. D Prendergast Infective endocarditis BMJ, August 12, 2006; 333(7563): 334 - 339. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Falagas, K. G. Manta, F. Ntziora, and K. Z. Vardakas Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence J. Antimicrob. Chemother., August 1, 2006; 58(2): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Baddour, J. M. Steckelberg, and W. R. Wilson Comment on: The role of aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials J. Antimicrob. Chemother., June 1, 2006; 57(6): 1255 - 1255. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Falagas, D. K. Matthaiou, and I. A. Bliziotis Aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: authors' response J. Antimicrob. Chemother., June 1, 2006; 57(6): 1255 - 1256. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Falagas, D. K. Matthaiou, and I. A. Bliziotis The role of aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials J. Antimicrob. Chemother., April 1, 2006; 57(4): 639 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gordon and F. D. Lowy Bacterial infections in drug users. N. Engl. J. Med., November 3, 2005; 353(18): 1945 - 1954. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Couri and P. V. Targonski 61-Year-Old Woman With Knee Pain and Confusion Mayo Clin. Proc., October 1, 2005; 80(10): 1363 - 1366. [PDF]
|
|